Treatment of Pseudomembranous Colitis
For initial episodes of pseudomembranous colitis, treat non-severe disease with oral metronidazole 500 mg three times daily for 10 days, and severe disease with oral vancomycin 125 mg four times daily for 10 days 1.
Disease Severity Assessment
Before initiating treatment, you must classify disease severity, as this directly determines antibiotic choice:
Non-severe disease is characterized by:
- Stool frequency <4 times daily
- Absence of severe colitis signs
Severe disease includes one or more of:
- Fever >38.5°C with rigors
- Hemodynamic instability or septic shock
- Peritoneal signs (decreased bowel sounds, tenderness, rebound, guarding)
- Ileus (vomiting, absent stool passage)
- Leukocytosis >15 × 10⁹/L or bandemia >20%
- Creatinine rise ≥50% above baseline
- Elevated serum lactate
- Imaging showing colonic distension, wall thickening, or pericolonic stranding 1
Initial Episode Treatment Algorithm
If Oral Therapy is Possible:
Non-severe disease:
- Metronidazole 500 mg orally three times daily for 10 days (A-I evidence) 1
Severe disease:
- Vancomycin 125 mg orally four times daily for 10 days (A-I evidence) 1
- Note: Higher doses of vancomycin (500 mg four times daily) show no additional benefit 1, 2
If Oral Therapy is Impossible (ileus, severe vomiting):
Non-severe disease:
- Metronidazole 500 mg IV three times daily for 10 days 1
Severe/complicated disease:
- Metronidazole 500 mg IV three times daily PLUS
- Vancomycin 500 mg in 100 mL normal saline retention enema every 4-12 hours intracolonically AND/OR
- Vancomycin 500 mg four times daily via nasogastric tube 1, 2
Critical Management Points
Stop the inciting antibiotic immediately if clinically feasible. For mild disease clearly induced by antibiotics, stopping the offending agent alone may suffice, but monitor closely for deterioration 1.
Avoid antiperistaltic agents and opiates - these worsen outcomes by preventing toxin clearance (B-II evidence) 1.
Assess treatment response at 3 days: Look for decreased stool frequency, improved consistency, and absence of new severe colitis signs. Metronidazole may take 3-5 days to show clinical response 2.
Surgical Intervention
Colectomy is indicated for:
- Colonic perforation
- Toxic megacolon (colon >6 cm diameter with systemic inflammatory response)
- Severe ileus not responding to medical therapy
- Clinical deterioration despite antibiotics
Operate before lactate exceeds 5.0 mmol/L - waiting until colitis becomes very severe increases mortality 1.
Recurrent Disease Management
First recurrence:
- Treat identically to initial episode based on severity 1
Second and subsequent recurrences:
- Vancomycin 125 mg orally four times daily for at least 10 days
- Consider taper/pulse strategy: decrease dose by 125 mg every 3 days, then pulse dosing (125 mg every 3 days for 3 weeks) (B-II evidence) 1
Multiple recurrences after standard therapy failure:
- Fecal microbiota transplantation achieves 92% resolution (95% CI 89-94%), with lower GI delivery superior to upper GI (95% vs 88%, p=0.02) 3
Important Caveats
The 2009 ESCMID guidelines 1 represent the most comprehensive evidence-based recommendations available in the provided literature. While newer agents like fidaxomicin exist 4, 2, the core treatment principles remain vancomycin for severe disease and metronidazole for non-severe disease.
Do not test for cure - stool may remain positive for weeks after clinical resolution 4.
Teicoplanin 100 mg twice daily may substitute for vancomycin if available 1.
Pseudomembranous colitis has non-C. difficile causes (ischemia, inflammatory bowel disease, other infections) 5, 6, so if C. difficile testing is negative and symptoms persist despite treatment, pursue colonoscopy with biopsy to identify alternative etiologies.